[{"Assets_0_Q1_USD":586980000.0,"CommonStockSharesOutstanding_0_Q1_shares":292302330.0,"EarningsPerShareBasic_1_Q1_USD":0.06,"EarningsPerShareDiluted_1_Q1_USD":0.05,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":68858000.0,"NetIncomeLoss_1_Q1_USD":16700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":309535000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":290870000.0,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170501"}]